Patents by Inventor Koei KOBAYASHI

Koei KOBAYASHI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240153010
    Abstract: An information processing apparatus (10) includes: an acquisition means (11) for acquiring information based on a sensor that measures information regarding a road; a generation means (12) for generating information indicating an accident situation according to a pattern of a traffic accident based on the information acquired by the acquisition means; and a transmission means (13) for transmitting the information indicating the accident situation generated by the generation means to an apparatus of an insurer.
    Type: Application
    Filed: March 10, 2021
    Publication date: May 9, 2024
    Applicant: NEC Corporatiom
    Inventors: Tetsuro Hasegawa, Hioakl Aminaka, Kazuki Ogata, Kei Yanagisawa, Koei Kobayashi
  • Patent number: 9771606
    Abstract: The genomic DNA of Streptoverticillium sp. 3-7, which produces UK-2, was analyzed to identify a region expected to be a UK-2 biosynthetic gene cluster. Moreover, by colony hybridization, DNAs in the region were successfully isolated. Further, the DNAs were used to prepare a strain in which the genes present in the region were disrupted. The strain was found not to produce UK-2. It was verified that the genomic region was the UK-2 biosynthetic gene cluster. Furthermore, Streptoverticillium sp. 3-7 was transformed by introduction of a vector in which the isolated UK-2 biosynthetic gene cluster was inserted. It was also found out that the UK-2 productivity by the transformant was improved about 10 to 60 times or more in comparison with that of the parental strain. Moreover, it was revealed that 2 copies of the UK-2 biosynthetic gene cluster were present per cell in these transformants, respectively.
    Type: Grant
    Filed: May 10, 2016
    Date of Patent: September 26, 2017
    Assignee: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Koei Kobayashi, Naomi Sumida, Koji Yanai
  • Publication number: 20160244793
    Abstract: To provide a production method capable of mass production of UK-2 at low cost, the genomic DNA of Streptoverticillium sp. 3-7, which produces UK-2, was analyzed to identify a region expected to be a UK-2 biosynthetic gene cluster. Moreover, by colony hybridization, DNAs in the region were successfully isolated. Further, the DNAs were used to prepare a strain in which the genes present in the region were disrupted. The strain was found not to produce UK-2. It was verified that the genomic region was the UK-2 biosynthetic gene cluster. Furthermore, Streptoverticillium sp. 3-7 was transformed by introduction of a vector in which the isolated UK-2 biosynthetic gene cluster was inserted. It was also found out that the UK-2 productivity by the transformant was improved about 10 to 60 times or more in comparison with that of the parental strain. Moreover, it was revealed that 2 copies of the UK-2 biosynthetic gene cluster were present per cell in these transformants, respectively.
    Type: Application
    Filed: May 10, 2016
    Publication date: August 25, 2016
    Applicant: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Koei KOBAYASHI, Naomi SUMIDA, Koji YANAI
  • Patent number: 9365879
    Abstract: The genomic DNA of Streptoverticillium sp. 3-7, which produces UK-2, was analyzed to identify a region expected to be a UK-2 biosynthetic gene cluster. Moreover, by colony hybridization, DNAs in the region were successfully isolated. Further, the DNAs were used to prepare a strain in which the genes present in the region were disrupted. The strain was found not to produce UK-2. It was verified that the genomic region was the UK-2 biosynthetic gene cluster. Furthermore, Streptoverticillium sp. 3-7 was transformed by introduction of a vector in which the isolated UK-2 biosynthetic gene cluster was inserted. It was also found out that the UK-2 productivity by the transformant was improved about 10 to 60 times or more in comparison with that of the parental strain. Moreover, it was revealed that 2 copies of the UK-2 biosynthetic gene cluster were present per cell in these transformants, respectively.
    Type: Grant
    Filed: July 8, 2013
    Date of Patent: June 14, 2016
    Assignee: MEIJI SEIKA PHARMA CO., LTD.
    Inventors: Koei Kobayashi, Naomi Sumida, Koji Yanai
  • Publication number: 20140011203
    Abstract: The genomic DNA of Streptoverticillium sp. 3-7, which produces UK-2, was analyzed to identify a region expected to be a UK-2 biosynthetic gene cluster. Moreover, by colony hybridization, DNAs in the region were successfully isolated. Further, the DNAs were used to prepare a strain in which the genes present in the region were disrupted. The strain was found not to produce UK-2. It was verified that the genomic region was the UK-2 biosynthetic gene cluster. Furthermore, Streptoverticillium sp. 3-7 was transformed by introduction of a vector in which the isolated UK-2 biosynthetic gene cluster was inserted. It was also found out that the UK-2 productivity by the transformant was improved about 10 to 60 times or more in comparison with that of the parental strain. Moreover, it was revealed that 2 copies of the UK-2 biosynthetic gene cluster were present per cell in these transformants, respectively.
    Type: Application
    Filed: July 8, 2013
    Publication date: January 9, 2014
    Inventors: Koei KOBAYASHI, Naomi SUMIDA, Koji YANAI